← Leaderboards
Alberto Ascherio
Harvard University D/B/A Harvard School Of Public Health
$33,649,459
Attributed
$33,649,459
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,149,874 · 16
ATSDR$1,499,585 · 1
By mechanism
R01$33,249,180 · 16
R21$400,279 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Prospective”
- David R. Weir · University Of Michigan At Ann Arbor$228,258,249
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Lawrence Corey · Fred Hutchinson Cancer Center$198,594,425
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Mary M Horowitz · Medical College Of Wisconsin$137,744,651
- Judith S Hochman · New York University School Of Medicine$110,738,390
Research focus
ProspectiveBlood SpecimenSamplingInvestigationFollow-UpRisk FactorsSmokingIncidenceWomanSerumMultiple SclerosisCigarette SmokingDesignAffectPharmaceutical PreparationsCohortDiagnosisBloodParticipantBaseProspective StudiesPreventionReportingNurses&Apos
Grant awards (78)
Elucidating the biological mechanisms underlying the association between EBV and MS in African Americans$763,865
R01 · FY2025 · AI · contact PI
Biomarkers and Risk Factors for Prodromal Parkinson's Disease and its Progression$659,131
R01 · FY2025 · NS · contact PI
Biomarkers and risk factors for prodromal Parkinson's disease and its progression$638,783
R01 · FY2024 · NS · contact PI
Prospective Study of Vitamin D and MS Risk in African Americans$320,615
R01 · FY2024 · NS · contact PI
Biomarkers and risk factors for prodromal Parkinson's disease and its progression$477,028
R01 · FY2023 · NS · contact PI
Prospective Study of Vitamin D and MS Risk in African Americans$426,578
R01 · FY2023 · NS · contact PI
Serological profiling of the human virome and ALS risk in a military population$499,585
R01 · FY2022 · TS · contact PI
Biomarkers and risk factors for prodromal Parkinson's disease and its progression$483,619
R01 · FY2022 · NS · contact PI
Serological profiling of the human virome and ALS risk in a military population$500,000
R01 · FY2021 · TS · contact PI
Serological profiling of the human virome and ALS risk in a military population$500,000
R01 · FY2020 · TS · contact PI
Prospective study of vitamin D and MS risk in African Americans$471,641
R01 · FY2020 · NS · contact PI
Metabolomics and risk of Parkinson's Disease$623,653
R01 · FY2019 · NS · contact PI
Prospective study of vitamin D and MS risk in African Americans$617,858
R01 · FY2019 · NS · contact PI
Metabolomics and risk of Parkinson's Disease$366,168
R01 · FY2019 · NS · contact PI
Prospective study of vitamin D and MS risk in African Americans$627,174
R01 · FY2018 · NS · contact PI
Metabolomics and risk of Parkinson's Disease$563,079
R01 · FY2018 · NS · contact PI
Metabolomics and risk of Parkinson's Disease$563,079
R01 · FY2017 · NS · contact PI
Metabolomics and risk of Parkinson's Disease$563,079
R01 · FY2016 · NS · contact PI
Prospective study of biomarkers and risk factors for ALS incidence and progressio$453,864
R01 · FY2016 · NS · contact PI
Metabolomics and risk of Parkinson's Disease$593,802
R01 · FY2015 · NS · contact PI
Prospective study of biomarkers and risk factors for ALS incidence and progressio$451,678
R01 · FY2015 · NS · contact PI
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip$308,960
R01 · FY2015 · NS · contact PI
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip$574,568
R01 · FY2014 · NS · contact PI
Prospective study of biomarkers and risk factors for ALS incidence and progressio$457,361
R01 · FY2014 · NS · contact PI
Prospective study of biomarkers and risk factors for ALS incidence and progressio$170,869
R01 · FY2014 · NS · contact PI
Vitamin D, cigarette smoking, EBV infection and risk of MS progression$72,621
R01 · FY2014 · NS · contact PI
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip$526,642
R01 · FY2013 · NS · contact PI
Urate as a Predictor of Parkinson's Disease Risk and Progression$508,191
R01 · FY2013 · NS · contact PI
Prospective study of biomarkers and risk factors for ALS incidence and progressio$363,251
R01 · FY2013 · NS · contact PI
Vitamin D, cigarette smoking, EBV infection and risk of MS progression$177,039
R01 · FY2013 · NS · contact PI
Urate as a Predictor of Parkinson's Disease Risk and Progression$694,904
R01 · FY2012 · NS · contact PI
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip$572,535
R01 · FY2012 · NS · contact PI
Prospective Study of Vitamin D and Multiple Sclerosis$503,287
R01 · FY2012 · NS · contact PI
Urate as a Predictor of Parkinson's Disease Risk and Progression$671,891
R01 · FY2011 · NS · contact PI
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip$628,142
R01 · FY2011 · NS · contact PI
Prospective Study of Vitamin D and Multiple Sclerosis$504,455
R01 · FY2011 · NS · contact PI
Vitamin D, cigarette smoking, EBV infection and risk of MS progression$92,291
R01 · FY2011 · NS · contact PI
Urate as a Predictor of Parkinson's Disease Risk and Progression$662,145
R01 · FY2010 · NS · contact PI
Prospective Study of Vitamin D and Multiple Sclerosis$505,661
R01 · FY2010 · NS · contact PI
Vitamin D, cigarette smoking, EBV infection and risk of MS progression$353,281
R01 · FY2010 · NS · contact PI
Prospective Epidemiological Study of ALS$290,761
R01 · FY2010 · NS · contact PI
Urate as a Predictor of Parkinson's Disease Risk and Progression$814,371
R01 · FY2009 · NS · contact PI
Prospective Study of Vitamin D and Multiple Sclerosis$498,504
R01 · FY2009 · NS · contact PI
NSAIDs, inflammation and Parkinson's disease$417,935
R01 · FY2009 · NS · contact PI
Pre-diagnostic markers of infection and risk of MS$359,598
R01 · FY2009 · NS · contact PI
Prospective Epidemiological Study of ALS$293,015
R01 · FY2009 · NS · contact PI
Molecular Epidemiology of EBV and Multiple Sclerosis$566,729
R01 · FY2008 · NS · contact PI
Prospective Study of Vitamin D and Multiple Sclerosis$515,014
R01 · FY2008 · NS · contact PI
NSAIDs, inflammation and Parkinson's disease$405,672
R01 · FY2008 · NS · contact PI
Pre-diagnostic markers of infection and risk of MS$359,598
R01 · FY2008 · NS · contact PI
Prospective Epidemiological Study of ALS$290,173
R01 · FY2008 · NS · contact PI
Molecular Epidemiology of EBV and Multiple Sclerosis$627,583
R01 · FY2007 · NS · contact PI
NSAIDs, inflammation and Parkinson's disease$405,582
R01 · FY2007 · NS · contact PI
Pre-diagnostic markers of infection and risk of MS$359,598
R01 · FY2007 · NS · contact PI
Organochlorine pesticide, PCBs, and Parkinsons$331,674
R01 · FY2007 · ES · contact PI
Prospective Epidemiological Study of ALS$300,929
R01 · FY2007 · NS · contact PI
Molecular Epidemiology of EBV and Multiple Sclerosis$627,497
R01 · FY2006 · NS · contact PI
NSAIDs, inflammation and Parkinson's disease$405,448
R01 · FY2006 · NS · contact PI
Pre-diagnostic markers of infection and risk of MS$370,338
R01 · FY2006 · NS · contact PI
Organochlorine pesticide, PCBs, and Parkinsons$341,581
R01 · FY2006 · ES · contact PI
Prospective Epidemiological Study of ALS$322,545
R01 · FY2006 · NS · contact PI
Molecular Epidemiology of EBV and Multiple Sclerosis$654,161
R01 · FY2005 · NS
NSAIDs, inflammation and Parkinson's disease$457,129
R01 · FY2005 · NS
Pre-diagnostic markers of infection and risk of MS$379,250
R01 · FY2005 · NS
Organochlorine pesticide, PCBs, and Parkinsons$365,800
R01 · FY2005 · ES
Prospective Study of Vitamin D and Multiple Sclerosis$246,000
R01 · FY2005 · NS
Prospective Epidemiological Study of ALS$307,800
R01 · FY2004 · NS
Prospective Study of Vitamin D and Multiple Sclerosis$245,813
R01 · FY2004 · NS
Prospective Epidemiological Study of ALS$307,800
R01 · FY2003 · NS
Pre-diagnostic markers of infection and risk of MS$292,126
R01 · FY2003 · NS
Epidemiology of cognitive dysfunction and Parkinson's$197,863
R21 · FY2003 · NS
Pre-diagnostic markers of infection and risk of MS$293,224
R01 · FY2002 · NS
Epidemiology of cognitive dysfunction and Parkinson's$202,416
R21 · FY2002 · NS
Pre-diagnostic markers of infection and risk of MS$323,897
R01 · FY2001 · NS
POOLING OF COHORT STUDIES ON DIET &CORONARY DISEASE$297,100
R01 · FY2001 · HL
DIETARY ETIOLOGIES OF MULTIPLE SCLEROSIS AND PARKINSONS$191,045
R01 · FY2001 · NS
POOLING OF COHORT STUDIES ON DIET &CORONARY DISEASE$288,446
R01 · FY2000 · HL
DIETARY ETIOLOGIES OF MULTIPLE SCLEROSIS AND PARKINSONS$183,071
R01 · FY2000 · NS